British Columbia


Canadian budtenders in training: A peek inside cannabis customer service courses

Vancouver-based company preparing dispensary staff to sell within the new legal framework.

Deep inside Simon Fraser University's halls, in the Morris J Wosk Centre for dialogue, a lecture was taking place.

There were students filling the seats, an eclectic crowd of young and old from a variety of ethnic backgrounds. At the front, an instructor was teaching using a PowerPoint presentation.

Standard university fare

Except in front of the teacher, lining a table, were several marijuana products, from dry bud, to balms, to concentrated tinctures. 

It was a two-day recreational retail course for the so-called "budtenders" of the future.


Aurora Cannabis to be lead investor in Choom Holdings private placement

Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it intends to complete a $7 million investment in Choom Holdings Inc. ("Choom") (CSE:CHOO) (OTCQB: CHOOF), whereby Aurora will receive 9,859,155 common shares from Choom's treasury, priced at $0.71 per share (the "Transaction"), representing an 8% ownership interest.


Aurora Cannabis to acquire Anandia

Anandia Laboratories Inc. ("Anandia" or "the Company"), a global leader in cannabis testing, genetics and R&D, is pleased to announce that it has signed a binding term sheet (the "Agreement") with Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) whereby Aurora will acquire all of the issued and outstanding shares of Anandia, valuing the Company at approximately $115 million, payable in units consisting of one common share of Aurora plus one half of a common-share purchase warrant for each common share of Aurora issued to Anandia.


Canada: System for enforcing recreational marijuana remains hazy

Marijuana businesses are growing in size and scope as Canada moves toward legalization of recreational pot, creating an increasingly daunting job for those tasked with enforcing the rules.

In Vancouver's bustling downtown, sleek, modern posters with fashionable fonts and simple images are plastered on lamp posts. It's not until you take a closer look that you spot the rolled joints inside a sandwich or buds among a plate of broccoli.

"Weed delivery. Simplified," the posters read.

Once an underground industry, marijuana delivery services are now advertising publicly, joining unlicensed retail stores and online shops as cannabis businesses openly skirting the existing law.


Zenabis receives cannabis sales license from Health Canada

Zenabis Ltd. (“Zenabis” or “the Company”), a licensed producer of medical cannabis, is pleased to announce that it has received its sales license from Health Canada. The sales license authorizes Zenabis to sell medicinal cannabis online at to registered medical patients across the country.

The addition of the cannabis sales license further solidifies Zenabis’ presence in the Canadian cannabis sector. The Company, which operates more than 400,000 square feet of licensed cannabis cultivation space, now has a fully licensed facility.


Canada: B.C. cannabis advocates warn craft producers could be left out

'This is not a greenfield economic activity. What we're asking for is people to be integrated into that system, rather than being shut out'.

British Columbia marijuana advocates are warning that thousands of small-scale producers could be left out of the upcoming legal adult market unless the federal and provincial governments change their approach to craft cannabis.

That would put a significant dent in B.C.’s economy and make it difficult for legal growers to undercut the black market, say five industry groups that signed an open letter, released Friday, to federal justice minister Jody Wilson-Raybould and B.C. Attorney General David Eby.


Canada: BC passes marijuana driving-impairment law, but confusion remains

B.C.’s top cop says he’s frustrated by Ottawa’s slow pace in selecting the roadside testing equipment that provinces will use to police drivers under the influence of soon-to-be-legal marijuana.

Solicitor General Mike Farnworth said it was difficult for B.C. to pass new legislation this week that sets out a ticketing and policing regime for drivers and cannabis, because it still doesn’t have details from Ottawa on what will be considered the federal standard for roadside drug-impairment testing.

“That’s again what is frustrating for us as a province,” he said Thursday. “And so what we’ve got to do is at least get the legislative framework that we can operate in place.”


BC and Ottawa sign marijuana tax-sharing deal

B.C. has signed on to Ottawa’s tax for legalized marijuana, though the province has not yet decided whether to share the money with local communities.

Finance Minister Carole James signed the “coordinated cannabis taxation agreement” with the federal government late last week, formalizing Ottawa’s offer to share 75 per cent of pot revenue with provinces and territories. The federal government had originally proposed a 50-50 split, but caved in December to pressure from provinces that argued they deserved a richer cut of the pending cash stream.


Exclusive: British Columbia announces plan to open retail locations under the name ‘BC Cannabis Stores’ and new legislation in preparation for legalization

The Government of British Columbia announced a new legislation proposal on Thursday in preparation for Canada to legalize marijuana this year.

The Government of British Columbia is proposing new rules making 19 the legal age to purchase, sell or consume cannabis, allow adults to possess up to 30 grams of cannabis in public spaces and ban smoking or vaping cannabis in the same places tobacco smoking and vaping in prohibited. The legislation will also ban smoking or vaping recreational cannabis at playgrounds and other places where children gather.


An eye drop that treats glaucoma while you sleep has been developed by scientists

An eye drop that treats glaucoma while you sleep has been developed by scientists.

It is based on a chemical found in cannabis and could end the misery of twice daily drops that are often ineffective.

The condition is triggered by a build-up of pressure that damages cells in the optic nerve. It is the second biggest cause of blindness. The breakthrough could lead to better therapies for other serious eye disorders – including macular degeneration which also destroys sight.

Professor Vikramaditya Yadav, a biomedical engineer at British Columbia University in Canada, said: “Medicated eye drops are commonly used to treat glaucoma – but they’re often poorly absorbed.


Subscribe to RSS - British Columbia